Sign in to view content

Agitation of the Syringe as a Cause of Inflammation After Intravitreal Injection of Aflibercept: A Randomized, Double-blind, Controlled Clinical Trial

Gustavo Barreto de Melo, MD, PhD, FASRS

Video
Published 2020

Related

OCT Angiography (OCTA) Monitors The Influence of Different VEGF-I Drugs on a Specific CNVM
Anne M. Hanneken, MD
Annual Meeting Talks
2018
Differences in Intravitreal Silicone Oil Following Multiple Bevacizumab, Ranibizumab, and Aflibercept Injections
John T. Thompson, MD
Updates from the Field
2019
Pradeepa Yoganathan Last Word
Pradeepa Yoganathan, MSc, MD, FRCS(C)
Annual Meeting Talks

Category: AMD-Neovascular

See more